Bergan Kdv Wealth Management, LLC Exagen Inc. Transaction History
Bergan Kdv Wealth Management, LLC
- $999 Million
- Q2 2023
A detailed history of Bergan Kdv Wealth Management, LLC transactions in Exagen Inc. stock. As of the latest transaction made, Bergan Kdv Wealth Management, LLC holds 2,500 shares of XGN stock, worth $9,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500Holding current value
$9,775% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XGN
# of Institutions
38Shares Held
6.41MCall Options Held
4.5KPut Options Held
400-
Rtw Investments, LP New York, NY1.51MShares$5.91 Million0.07% of portfolio
-
Cowen And Company, LLC891KShares$3.49 Million0.07% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY541KShares$2.11 Million0.01% of portfolio
-
Stonepine Capital Management, LLC Bend, OR534KShares$2.09 Million1.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.92 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $63.6M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...